The new "Position statement of the ADA/EASD on the management of hyperglycemia in type 2 diabetes". Point of view of the Spanish Diabetes Society Consensus and Clinical Guidelines Working Group

被引：1
|
作者：
Menendez Torre, Edelmiro [1 ]
机构：
[1] Hosp Univ Cent Asturias, Serv Endocrinol & Nutr, Oviedo, Spain
来源：
AVANCES EN DIABETOLOGIA | 2012年 / 28卷 / 04期
关键词：
D O I：
10.1016/j.avdiab.2012.07.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [31] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (vol 55, pg 1577, 2012)
    Inzucchi, S. E.
    Bergenstal, R. M.
    Buse, J. B.
    Diamant, M.
    Ferrannini, E.
    Nauck, M.
    Peters, A. L.
    Tsapas, A.
    Wender, R.
    Matthews, D. R.
    DIABETOLOGIA, 2013, 56 (03) : 680 - 680
  • [32] Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)
    John B. Buse
    Deborah J. Wexler
    Apostolos Tsapas
    Peter Rossing
    Geltrude Mingrone
    Chantal Mathieu
    David A. D’Alessio
    Melanie J. Davies
    Diabetologia, 2020, 63 : 1667 - 1667
  • [33] Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy - A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults
    Fritsche, Andreas
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (09) : 500 - 503
  • [34] Diabetestherapie: Was hat sich geändert?Management of hyperglycaemia in type 2 diabetes. Consensus Report 2018 by the ADA and EASD
    Michael Dietlein
    MMW - Fortschritte der Medizin, 2019, 161 (16) : 55 - 56
  • [35] New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective
    Katsiki, Niki
    Ferrannini, Ele
    Mantzoros, Christos
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 107
  • [36] Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (vol 61, pg 2461, 2018)
    Davies, Melanie J.
    D'Alessio, David A.
    Fradkin, Judith
    Kernan, Walter N.
    Mathieu, Chantal
    Mingrone, Geltrude
    Rossing, Peter
    Tsapas, Apostolos
    Wexler, Deborah J.
    Buse, John B.
    DIABETOLOGIA, 2019, 62 (05) : 873 - 873
  • [37] Management of Hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - Update regarding thiazolidinediones: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan, David M.
    Buse, John B.
    Davidson, Mayer B.
    Ferrannini, Ele
    Holman, Rury R.
    Sherwin, Robert
    Zinman, Bernard
    DIABETES CARE, 2008, 31 (01) : 173 - 175
  • [38] Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
    Inzucchi, Silvio E.
    Bergenstal, Richard M.
    Buse, John B.
    Diamant, Michaela
    Ferrannini, Ele
    Nauck, Michael
    Peters, Anne L.
    Tsapas, Apostolos
    Wender, Richard
    Matthews, David R.
    DIABETES CARE, 2015, 38 (01) : 140 - 149
  • [39] Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
    Yang, Ye Seul
    Kim, Hack-Lyoung
    Kim, Sang-Hyun
    Moon, Min Kyong
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 1 - 9
  • [40] Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of sherapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes - Response to Nathan et al
    Cryer, Philip E.
    DIABETES CARE, 2007, 30 (01) : 190 - 192
12345